Optimizing COVID-19 candidate therapeutics: Thinking Without Borders.

This commentary seeks to share some key insights relevant to optimizing COVID-19 candidate therapeutics that were learned from attempts to optimize anti-infective posology in settings where quality and timely availability of data is challenging, with particular focus on influenza, including experiences from H5N1 and pH1N1 outbreaks.

keywords 🔗 COVID-19 (1240) 🔗 antiviral (546) 🔗 clinical pharmacology () 🔗 coronavirus (5664) 🔗 drug development (25)

author 👤 Rayner, Craig R 👤 Smith, Patrick F 👤 Hershberger, Kevin 👤 Wesche, David

year ⏰ 2020

journal 📚 Clin Transl Sci

issn 🗄

volume

number

page

doi 📄 10.1111/cts.12790 ⤴

citedbycount 0

download 🔖 [BibTeX]